Stay updated on ARGX-113 in Myasthenia Gravis: Safety Trial
Sign up to get notified when there's something new on the ARGX-113 in Myasthenia Gravis: Safety Trial page.

Latest updates to the ARGX-113 in Myasthenia Gravis: Safety Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added and the older funding-status notice (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedA site-wide notice about government funding status and NIH Clinical Center operations has been added. The page revision version was updated from 3.4.0 to 3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedThe page now shows a glossary and the field 'Last Update Submitted that Met QC Criteria.' A new revision label 'v3.4.0' was added, replacing 'v3.3.4,' and there are capitalization updates to 'No FEAR Act' data.SummaryDifference0.2%

- Check64 days agoChange DetectedThe study locations are reorganized to show individual sites by region (e.g., California, Florida, Ontario, Tokyo), and the HHS Vulnerability Disclosure footer was removed.SummaryDifference1%

- Check92 days agoChange DetectedMinor editorial notes were added indicating PubMed data sourcing for publications and updating the page revision to v3.3.2, which do not affect core study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check99 days agoChange DetectedThe page no longer displays the government funding and operating status notice, which was previously shown to inform users about potential delays and updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to ARGX-113 in Myasthenia Gravis: Safety Trial
Enter your email address, and we'll notify you when there's something new on the ARGX-113 in Myasthenia Gravis: Safety Trial page.